F-star: F-star Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023

F-star Therapeutics, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was GBP 19.53 million compared to GBP 13.1 million a year ago. Net income was GBP 33.42 million compared to net loss of GBP 41.93 million a year ago. F-star Therapeutics, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was GBP 19.53 million compared to GBP 13.1 million a year ago. Net income was GBP 33.42 million compared to net loss of GBP 41.93 million a year ago.